Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DDB1- and CUL4-associated factor 4-like protein 1 (DCAF4L1) is a member of the DCAF (DDB1 and CUL4-associated factor) protein family, which typically serve as substrate receptors for the Cullin 4 (CUL4)-based E3 ubiquitin ligase complexes (CRL4)[4][5][7]. DCAF4L1 contains WD repeat motifs, which are involved in mediating protein-protein interactions, and likely enables the recognition of specific substrate proteins for ubiquitination and subsequent degradation via the proteasome pathway[4][5]. While functional studies for DCAF4L1 itself are limited, other DCAF family members play roles in cell cycle regulation, DNA repair, and chromatin remodeling as part of CRL4 complexes[1][2]. There is currently no evidence that DCAF4L1 is a direct drug target, or that it plays a role in human disease pathogenesis or therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DDB1- and CUL4-associated factor 4-like protein 1 (DCAF4L1).